Avizakimab
Avizakimab (BOS161721) is a humanized IgG1 monoclonal antibody that targets interleukin-21[1].
Product Specifications
CAS Number
2229685-51-0
Product Name Alternative
BOS161721
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/avizakimab.html
Purity
99.35
Solubility
H2O
Smiles
[Avizakimab]
Molecular Weight
(145.2 kDa)
References & Citations
[1]Hussaini A, et al. A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects. Clin Transl Sci. 2020 Mar;13 (2) :337-344.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC-16645-01 50 μL
Recombinant c-Jun (phospho S73) /JunD (phospho S100) Antibody
Sign In for Pricing
View Details